Factor Therapeutics Limited, formerly Tissue Therapies Limited, is an Australia-based biomedical technology company. The Company is engaged in developing treatments for acute and chronic wound healing applications, including chronic skin ulcers and burns. The Company is engaged in commercializing VitroGro ECM for the treatment of venous leg ulcers and diabetic foot ulcers. VitroGro is a broad spectrum healing promoter for the treatment of a range of ulcers. The Company has conducted a VITRO-CARD-1001 study using VitroGro ECM in a population of patients. VitroGro ECM binds collagen in skin, and is adsorbed onto the wound bed and not absorbed into the underlying tissues. As a consequence, the action of VitroGro ECM is localized to the wound bed. VitroGro ECM acts as a scaffold, which enables cell attachment. Tissue Therapies Europe Limited is the Company's subsidiary.